Angelalign Technology's Subsidiary to Purchase Raw Materials for Aligner Production

MT Newswires Live
02-20

Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.

The materials will be used for the production of clear aligners.

The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10